The global omega-3 concentrates market was valued at US$ 1,635.39 million in 2019 and is projected to reach US$ 2,703.20 million by 2027; it is expected to grow at a CAGR of 6.6% during 2020–2027.
Omega-3 concentrates refer to highly concentrated oils comprising the EPA and DHA that sum up more than 50%.These concentrates are obtained from omega-3 rich fats processed to have EPA or DHA in higher concentrations.
The omega-3 concentrates are mainly derived from oils such as fish oil, calamari oil, and algal oil.These concentrates are also available in powdered forms and find their application in dietary supplement manufacturing and are also used as a pharmaceutical-grade component.
The plethora of health benefits and attributes offered by omega-3 concentrates are the key factors driving the growth of the omega-3 concentrates market.However, the lack of awareness and a wide gap between the usage and awareness restricts the profitable growth of the omega-3 concentrates market.
The increasing disposable income of the consumers in emerging economies of regions, such as the Asia Pacific, Middle East, and Africa, and South America, contributes to the market growth. Consumers in these regions are increasingly spending on dietary supplements and healthy foods due to the rising disposable income and improving lifestyles. In addition to this, key players and suppliers actively involved in the supply chain of omega-3 concentrates are developing various strategies to expand the awareness regarding the health benefits associated with omega-3 enriched diets, which has widely and positively influenced the sales of omega-3 concentrates in the developing regions. Manufacturers are also offering gluten-free, and non-GMO omega-3 concentrates. For instance, Solgar Inc. offers non-GMO, gluten, wheat, and dairy-free omega-3 fish oil concentrates. Therefore, the product launches that can satisfy a broad spectrum of consumers are also amplifying the market progression.
Based on form, the omega 3 concentrates market is segmented into oil and powder.In 2019, the oil segment dominated the market.
The omega-3 concentrate is a highly concentrated oil that contains EPA and DHA with a sum concentration of more than 50%.Omega-3 concentrates are majorly obtained from omega-3 rich oils that are further processed to obtain a higher EPA and/or DHA concentration.
These can be obtained from several omega-3 rich oils such as alga oil, fish oil, calamari oil, etc.The richest and the cheapest source of EPA/DHA is fish oil.
Fish oil contains 30-60 different fatty acids. Fish oil is an industrial product of high nutritional value due to its content of long-chain omega-3 polyunsaturated fatty acids (PUFA), such as Docosahexaenoic acid (DHA), and Eicosapentaenoic acid (EPA), which are currently extremely valued for their prophylactic and therapeutic properties in nutritional and health fields. Moreover, the market for highly concentrated omega-3 fatty acid fish oils for pharmaceuticals and supplements is growing.
In terms of geography, the omega 3 concentrates market is segmented into North America, Europe, Asia Pacific (APAC), South America, and Middle East & Africa (MEA).North America held the largest share of the global omega 3 concentrates market in 2019, followed by Asia Pacific and Europe.
North America comprises several developing economies, such as US, Canada and Mexico.The demand for omega-3 concentrates is expected to increase in the region with the rising importance of EPA and DHA.
EPA and DHA are becoming a part of the North American consumer’s regular diet due to the increased prevalence of lifestyle ailments and people taking precautionary healthcare measures.Besides, the growing applications of EPA and DHA in food and dietary supplements and clinical nutrition further stimulate omega-3 concentrates market growth in North America.
Also, omega-3 oils are vital fatty acids that have a wide range of health advantages for eye, cardiovascular, and brain health, for which omega-3 concentrates are extensively used in the multiple end-user applications, such as infant nutrition, dietary supplements, functional food & beverages, pharmaceutical in the region, thus driving the North America omega-3 concentrates market. Asia Pacific is estimated to register the fastest CAGR in the market during the forecast period. The rapid growth of this region is primarily attributed to the shift in consumer inclination toward a healthy diet containing omega-3 ingredients and the use of fish oil in Southeast Asia is anticipated to boost the omega-3 concentrates market in the Asia Pacific region.
COVID-19 outbreak started in Wuhan, China, in December 2019 and has spread across the globe.The US, India, Brazil, Russia, the UK, France, Spain, Italy, Turkey, and Germany are among the most-affected nations in terms of confirmed cases and reported deaths, as of January, 2021.
According to the WHO, there are ~99,864,391 affirmed cases and 2,149,700 death cases all around.COVID-19 has affected economies and undertakings due to lockdowns, travel bans, and business shutdowns.
The global food & beverages industry is one of the major businesses enduring severe impacts. These has highly affected the worldwide omega 3 concentrates market.
BASF SE; AlaskOmega Golden Omega S.A.; K Pharmtech Co., Ltd.; DSM Nutritional Products AG; Nordic Naturals, Inc.; Epax Norway; Norwegian Fish Oil; GC Rieber VivoMega; and Australian Omega Oils Pty. Ltd. are among the major players present in the global omega 3 concentrates market.
Overall size of the global omega 3 concentrates market size has been derived in accordance with both primary and secondary sources.To begin the research process begins exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market.
Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data as well as to gain more analytical insights into the topic. The participants typically involved in the process include industry experts, such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants, such as valuation experts, research analysts, and key opinion leaders specialized in the omega 3 concentrates.
Our reports have been used by over 10K customers, including:
According to MarketsandMarkets, the global functional proteins market size is estimated to be valued at USD 4.6 billion in 2020 and projected to reach USD 6.1 billion by 2025, recording a CAGR of 5.6% during the forecast period. The growing prevalence of chronic diseases and rising awareness regarding health-beneficiary on-the-go supplements...
The beta-glucan market is estimated at USD 403.8 million in 2020 and is projected to grow at a CAGR of 7.6%, to reach USD 628.3 million by 2026. The ongoing health and wellness trend is spreading across the world, with the growing consumer awareness regarding dietary deficiency and the health benefits of consuming fiber. Nowadays, consumers...
The global functional proteins market was valued at US$ 10,297.91 million in 2019 and is projected to reach US$ 17,767.48 million by 2027; it is expected to grow at a CAGR of 7.2% from 2020 to 2027. Consumers are more inclined toward wellness, health, and nutrition content.Food industry is continuously introducing new products considering...
The global dietary supplements market size is estimated to be valued at USD 136.2 billion in 2020 and projected to reach USD 204.7 billion by 2026, recording a CAGR of 7.0% during the forecast period. The growing prevalence of chronic diseases and growing awareness regarding on-the-go supplements supporting better health among consumers are...
The women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period. In the past decade, the demand for various health diagnostic tests has increased significantly across the globe. Currently, the market is mainly driven by growing awareness about...
80 pages •
By Euromonitor International
• Nov 2020
Consumer health is expected to see higher current value growth in 2020 than was seen the previous year. One of the factors driving growth in this year is COVID-19. As news about the virus emerged and the country went into lockdown, consumers began panic-buying in March, stockpiling certain consumer health products, such as analgesics, cough,...
94 pages •
By Euromonitor International
• Nov 2020
With Kenyans mired in the COVID-19 pandemic, it is perhaps not surprising that value sales of consumer health products are set to rise in 2020 at a rate higher than those recorded during the review period. Broadly, a pandemic-inspired heightened focus on maintaining/improving health is driving greater interest in over the counter (OTC) health...
111 pages •
By Euromonitor International
• Nov 2020
Consumer health is expected to see lower current value growth in 2020 than was seen the previous year, largely as a result of COVID-19. The hardest hit categories in 2020 are likely to be sports nutrition and weight management. The demand for these products was significantly dampened due to the introduction of lockdown restrictions, which...
91 pages •
By Euromonitor International
• Nov 2020
The main developments in consumer health in Costa Rica in 2020 as a result of COVID-19 are related to the sudden spike in the sales of vitamins and dietary supplements, particularly those associated to immunity responses. For example, echinacea has gained significant awareness amongst local consumers in 2020. COVID-19 resulted in shortages...
90 pages •
By Euromonitor International
• Nov 2020
COVID-19 will have a significant effect on current value sales growth in consumer health during 2020, but the impact will not be uniformly negative. Wound care will be particularly badly affected, as people are spending less time on the move and out of doors due to restrictions introduced to curb the spread of the virus. As a result, they...
OTC
Dietary Supplement
Healthcare
Lithuania
World
United States
Vitamin Sales
Analgesic Medicine Sales
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.
